ThaiPR.NET https://www.thaipr.net/location/lausanne-switzerland Press Release Distribution Center of Thailand Fri, 10 Apr 2026 17:30:46 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[Bata Group Celebrates Founder’s Day: A Global Day to Remember and to Give Back]]> https://www.thaipr.net/en/business_en/3377168 Thu, 31 Aug 2023 16:45:00 +0700 business_en https://www.thaipr.net/en/business_en/3377168 Bata Group, the renowned footwear brand with a rich heritage, is excited to announce the upcoming celebration of its annual Founder’s Day on September 21, 2023. This global event commemorates the remarkable journey of Bata and brings together employees, customers, and communities worldwide to embrace the spirit of unity. Founder’s Day holds immense significance for […]

The post Bata Group Celebrates Founder’s Day: A Global Day to Remember and to Give Back appeared first on ThaiPR.NET.

]]> <![CDATA[Airbus Extends Partnership with Astrocast to Further Enhance Satellite IoT Technology]]> https://www.thaipr.net/en/it_en/3362085 Mon, 24 Jul 2023 14:04:00 +0700 it_en https://www.thaipr.net/en/it_en/3362085 Airbus partnership extension reaffirms commitment to support Astrocast’s SatIoT technology roadmap, reinforcing Astrocast’s position as the leading provider of cost-effective and reliable satellite IoT solutions. Astrocast, a leading satellite IoT operator, announces the extension of its partnership with Airbus Defence and Space (Airbus), a global leader in the aerospace industry. This partnership enhances the capabilities […]

The post Airbus Extends Partnership with Astrocast to Further Enhance Satellite IoT Technology appeared first on ThaiPR.NET.

]]> <![CDATA[DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM]]> https://www.thaipr.net/en/health_en/3317851 Thu, 23 Mar 2023 08:10:24 +0700 health_en https://www.thaipr.net/en/health_en/3317851 Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the first patient dosed of their first-in-human, phase 1/2 study, GaLuCi™. The first patient was screened and dosed at the Australian-based Peter MacCallum Cancer Centre. This multicenter international trial, evaluating a radioligand theranostic pair will be […]

The post DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM appeared first on ThaiPR.NET.

]]> <![CDATA[DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY]]> https://www.thaipr.net/en/health_en/3309516 Thu, 02 Mar 2023 16:17:54 +0700 health_en https://www.thaipr.net/en/health_en/3309516 Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having obtained the global rights for FT-3171, a small molecule USP1 inhibitor program targeting a novel DNA […]

The post DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY appeared first on ThaiPR.NET.

]]> <![CDATA[DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS]]> https://www.thaipr.net/en/health_en/3290445 Thu, 12 Jan 2023 16:04:26 +0700 health_en https://www.thaipr.net/en/health_en/3290445 –  Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. –  Debiopharm is developing Debio 4126, a novel 3-month extended-release octreotide formulation, to optimize acromegaly and GEP-NET patient care by reducing injection frequency, which translates into an improved […]

The post DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS appeared first on ThaiPR.NET.

]]> <![CDATA[DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY]]> https://www.thaipr.net/en/health_en/3247539 Mon, 03 Oct 2022 14:14:24 +0700 health_en https://www.thaipr.net/en/health_en/3247539 Debiopharm awards the winning scientists for the JCA (Japanese Cancer Association) Award for innovative, disruptive, and translational oncology research   Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research – Dr. Akihide Yoshimi and for Translational Research – Prof. Mamiko […]

The post DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY appeared first on ThaiPR.NET.

]]> <![CDATA[Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence]]> https://www.thaipr.net/en/health_en/3238749 Wed, 14 Sep 2022 09:00:00 +0700 health_en https://www.thaipr.net/en/health_en/3238749 Debiopharm Innovation Fund strategically invests in Whitelab Genomics’ mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm (www.Debiopharm.com), announced today their investment in Whitelab Genomics alongside French Venture Capital company, Omnes Capital, in […]

The post Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence appeared first on ThaiPR.NET.

]]> <![CDATA[ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS]]> https://www.thaipr.net/en/health_en/3236668 Thu, 08 Sep 2022 15:20:56 +0700 health_en https://www.thaipr.net/en/health_en/3236668 International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the threat of AMR Debiopharm will join the action-focused discussions around […]

The post ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS appeared first on ThaiPR.NET.

]]> <![CDATA[Philips Projection introduces the Philips Screeneo U4]]> https://www.thaipr.net/en/it_en/3201757 Wed, 15 Jun 2022 08:15:00 +0700 it_en https://www.thaipr.net/en/it_en/3201757 The company’s all-new Ultra-Short-Throw projector. Philips Projection is delighted to announce the launch of the Philips Screeneo U4, an ultra-short-throw projector that provides an 80″ True Full HD picture while positioned as close as 12″ (30.5cm) away. Exclusively available for pre-order on the online innovation platform, Indiegogo, the Screeneo U4 has already received great interest from thousands […]

The post Philips Projection introduces the Philips Screeneo U4 appeared first on ThaiPR.NET.

]]> <![CDATA[DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES]]> https://www.thaipr.net/en/health_en/3179576 Tue, 12 Apr 2022 08:15:00 +0700 health_en https://www.thaipr.net/en/health_en/3179576 Pre-clinical & clinical exploratory poster presentations to highlight oncology results withDebio 0123, xevinapant, and Multilink™ technology for antibody drug conjugates Debiopharm, (www.debiopharm.com/debiopharm-international/) an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective WEE1 inhibitor), clinical exploratory results for xevinapant (IAP inhibitor), and […]

The post DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES appeared first on ThaiPR.NET.

]]> <![CDATA[Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study]]> https://www.thaipr.net/en/health_en/3134886 Thu, 16 Dec 2021 15:22:40 +0700 health_en https://www.thaipr.net/en/health_en/3134886 Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly launched open-label, phase I study evaluating Debio 0123, an oral, potent and highly selective WEE1 inhibitor, as monotherapy […]

The post Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study appeared first on ThaiPR.NET.

]]> <![CDATA[Philips Projection Sets to Redefine Our Viewing Experience with the Launch of Two New Portable Projectors]]> https://www.thaipr.net/en/it_en/3112088 Thu, 21 Oct 2021 08:00:00 +0700 it_en https://www.thaipr.net/en/it_en/3112088 Philips Projection is today adding two new products to their family of high-performance projectors with the release of the all-in-one entertainment unit, the Philips PicoPix MaxTV, and the Philips GoPix 1, the first product of a new family of smartphones’ companion projectors. Whether you are a value seeker, a freedom lover, cinema addict, or a design enthusiast, each Philips […]

The post Philips Projection Sets to Redefine Our Viewing Experience with the Launch of Two New Portable Projectors appeared first on ThaiPR.NET.

]]> <![CDATA[Debiopharm Encourages Breakthrough Cancer Research in Japan Through its Competitive JCA Mauvernay Award]]> https://www.thaipr.net/en/health_en/3105575 Mon, 04 Oct 2021 14:15:27 +0700 health_en https://www.thaipr.net/en/health_en/3105575 Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research – Dr. Shumpei Ishikawa and Translational Research – Dr. Hiromichi Ebi. The winners were honored with trophies and a monetary prize during the hybrid (virtual/live) meeting […]

The post Debiopharm Encourages Breakthrough Cancer Research in Japan Through its Competitive JCA Mauvernay Award appeared first on ThaiPR.NET.

]]> <![CDATA[Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples]]> https://www.thaipr.net/en/health_en/3092991 Wed, 01 Sep 2021 08:00:00 +0700 health_en https://www.thaipr.net/en/health_en/3092991 Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA samples. BRB-seq is Alithea’s flagship technology and is based on early sample barcoding and pooling. With BRB-seq, right after the […]

The post Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples appeared first on ThaiPR.NET.

]]> <![CDATA[Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases]]> https://www.thaipr.net/en/health_en/3048426 Thu, 22 Apr 2021 14:14:05 +0700 health_en https://www.thaipr.net/en/health_en/3048426 –  Launching in May, an inaugural four-part webinar series Unmasking Facial Skin & Dermatoses will feature expert presentations from world-renowned dermatologists –  The program launches the Galderma Excellence in Multichannel Medical Education (GEMME) platform, demonstrating its commitment to innovative and science-led approaches in skin health Galderma today announces the launch of its Galderma Excellence in Multichannel Medical […]

The post Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases appeared first on ThaiPR.NET.

]]> <![CDATA[#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month]]> https://www.thaipr.net/en/health_en/3048114 Wed, 21 Apr 2021 16:45:24 +0700 health_en https://www.thaipr.net/en/health_en/3048114 – Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition – #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular mask-wearing on their rosacea Galderma is uniting rosacea sufferers from around the globe in an empowering […]

The post #RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month appeared first on ThaiPR.NET.

]]> <![CDATA[Nespresso invests CHF 117 million in the expansion of its Avenches production center to meet growing consumer demand]]> https://www.thaipr.net/en/business_en/3039235 Thu, 18 Mar 2021 14:45:57 +0700 business_en https://www.thaipr.net/en/business_en/3039235 Nespresso invests CHF 117 million to expand its Avenches production center in Switzerland to meet increasing consumer demand for its high-quality premium coffees and support international development, creating 50 new jobs by the end of 2022. The investment supports the increase of production capacity, by including three new production lines, and the expansion of its distribution […]

The post Nespresso invests CHF 117 million in the expansion of its Avenches production center to meet growing consumer demand appeared first on ThaiPR.NET.

]]> <![CDATA[Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease]]> https://www.thaipr.net/en/health_en/3030693 Fri, 19 Feb 2021 13:19:08 +0700 health_en https://www.thaipr.net/en/health_en/3030693 – Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic skin disease – Despite worsening of signs and symptoms, only a third (33%) of respondents have visited a […]

The post Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease appeared first on ThaiPR.NET.

]]> <![CDATA[Tetra Pak calls for collaborative innovation to tackle sustainability challenges in the food packaging industry]]> https://www.thaipr.net/en/general_en/3023092 Thu, 28 Jan 2021 08:10:08 +0700 general_en https://www.thaipr.net/en/general_en/3023092 Tetra Pak has introduced a new collaborative innovation model with leading paperboard producers, a move aimed at tackling the food packaging industry’s sustainability challenges. The traditional operating model of a linear supply chain has changed, and a new partnership ecosystem model is emerging, where the entire industry works in close collaboration. This brings together not only […]

The post Tetra Pak calls for collaborative innovation to tackle sustainability challenges in the food packaging industry appeared first on ThaiPR.NET.

]]>